Strongyloides hyperinfection syndrome and transplantation: A preventable, frequently fatal infection: Editorial

Transplant Infectious Disease

Volumn 11, Issue 2, 2009, Pages 97-99

  Marty, Francisco M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; CYCLOSPORIN; IVERMECTIN;

CLINICAL FEATURE; DISEASE COURSE; DRUG CHOICE; EDITORIAL; EOSINOPHILIA; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOCOMPROMISED PATIENT; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; MORBIDITY; MORTALITY; PRIORITY JOURNAL; SINGLE DRUG DOSE; STRONGYLOIDES RATTI; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS; TRANSPLANTATION;

ANIMALS; ANTHELMINTICS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ORGAN TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS; SUPERINFECTION;

EID: 64249122181     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2009.00383.x     Document Type: Editorial

References (24)

1. Rubin RH. Infection in the organ transplant recipient. In : Rubin RH, Young LS, eds. Clinical Approach to Infection in the Compromised Host (4th edn). New York : Kluwer Academic/Plenum, 2002 : 573 679.
2. Siddiqui AA, Genta RM, Berk SL. Strongyloidiasis. In : Guerrant RL, Walker DH, Weller PF, eds. Tropical Infectious Diseases: Principles, Pathogens & Practice (2nd edn). Philadelphia : Elsevier Churchill Livingstone, 2006 : 1274 1285.
3. Lichtenberger P, Rosa-Cunha I, Morris M, et al. Hyperinfection strongyloidiasis in a liver transplant recipient treated with parenteral ivermectin. Transpl Infect Dis 2009 11 (2) : 137 142.
4. Vilela EG, Clemente WT, Mira RRL, et al. Strongyloides stercoralis hyperinfection syndrome after liver transplantation: case report and literature review. Transpl Infect Dis 2009 11 (2) : 132 136.
5. Balagopal A, Mills L, Shah A, Subramanian A. Detection and treatment of Strongyloides hyperinfection syndrome following lung transplantation. Transpl Infect Dis 2009 11 (2) : 149 154.
6. Fagundas LA, Busato O, Brentano L. Strongyloidiasis: fatal complication of renal transplantation. Lancet 1971 2 (7721) : 439 440.
7. DeVault GA Jr., King JW, Rohr MS, Landreneau MD, Brown ST 3rd., McDonald JC. Opportunistic infections with Strongyloides stercoralis in renal transplantation. Rev Infect Dis 1990 12 (4) : 653 671.
8. Keiser PB, Nutman TB. Strongyloides stercoralis in the immunocompromised population. Clin Microbiol Rev 2004 17 (1) : 208 217.
9. Marcos LA, Terashima A, Dupont HL, Gotuzzo E. Strongyloides hyperinfection syndrome: an emerging global infectious disease. Trans R Soc Trop Med Hyg 2008 102 (4) : 314 318.
10. Wirk B, Wingard JR. Strongyloides stercoralis hyperinfection in hematopoietic stem cell transplantation. Transpl Infect Dis 2009 11 (2) : 143 148.
11. Valar C, Keitel E, Dal Pra RL, et al. Parasitic infection in renal transplant recipients. Transplant Proc 2007 39 (2) : 460 462.
12. CDC. Results of testing for intestinal parasites by state diagnostic laboratories, United States, 1987. MMWR Morb Mortal Wkly Rep 1992 41 (8) : 145 146.
13. Genta RM. Global prevalence of strongyloidiasis: critical review with epidemiologic insights into the prevention of disseminated disease. Rev Infect Dis 1989 11 (5) : 755 767.
14. Hoy WE, Roberts NJ Jr., Bryson MF, et al. Transmission of strongyloidiasis by kidney transplant? Disseminated strongyloidiasis in both recipients of kidney allografts from a single cadaver donor. JAMA 1981 246 (17) : 1937 1939.
15. Said T, Nampoory MR, Nair MP, et al. Hyperinfection strongyloidiasis: an anticipated outbreak in kidney transplant recipients in Kuwait. Transplant Proc 2007 39 (4) : 1014 1015.
16. Patel G, Arvelakis A, Sauter BV, Gondolesi GE, Caplivski D, Huprikar S. Strongyloides hyperinfection syndrome after intestinal transplantation. Transpl Infect Dis 2008 10 (2) : 137 141.
17. Schad GA. Cyclosporine may eliminate the threat of overwhelming strongyloidiasis in immunosuppressed patients. J Infect Dis 1986 153 (1) : 178.
18. Palau LA, Pankey GA. Strongyloides hyperinfection in a renal transplant recipient receiving cyclosporine: possible Strongyloides stercoralis transmission by kidney transplant. Am J Trop Med Hyg 1997 57 (4) : 413 415.
19. Tarr PE, Miele PS, Peregoy KS, Smith MA, Neva FA, Lucey DR. Case report: rectal administration of ivermectin to a patient with Strongyloides hyperinfection syndrome. Am J Trop Med Hyg 2003 6 (4) : 453 455.
20. Chiodini PL, Reid AJ, Wiselka MJ, Firmin R, Foweraker J. Parenteral ivermectin in Strongyloides hyperinfection. Lancet 2000 355 (9197) : 43 44.
21. Marty FM, Lowry CM, Rodriguez M, et al. Treatment of human disseminated strongyloidiasis with a parenteral veterinary formulation of ivermectin. Clin Infect Dis 2005 41 (1) : e5 e8.
22. Turner SA, Maclean JD, Fleckenstein L, Greenaway C. Parenteral administration of ivermectin in a patient with disseminated strongyloidiasis. Am J Trop Med Hyg 2005 73 (5) : 911 914.
23. Leung V, Al-Rawahi GN, Grant J, Fleckenstein L, Bowie W. Case report: failure of subcutaneous ivermectin in treating Strongyloides hyperinfection. Am J Trop Med Hyg 2008 79 (6) : 853 855.
24. Suputtamongkol Y, Kungpanichkul N, Silpasakorn S, Beeching NJ. Efficacy and safety of a single-dose veterinary preparation of ivermectin versus 7-day high-dose albendazole for chronic strongyloidiasis. Int J Antimicrob Agents 2008 31 (1) : 46 49.